Got $5,000? Here Are 2 Top Growth Stocks to Buy for July

Elanco is one of the largest animal health companies in the world, and buying shares of the business can be a great way to gain exposure to the growing pet health market. Although Elanco's revenue rose by 46% last year to $4.8 billion, the company is only forecasting revenue growth between 2% and 3% this year (that's after excluding the negative impact of foreign currency). One problem for investors is that the bulk of Elanco's revenue (55% last year) comes from international markets, which can add volatility.